Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
1121 5 |
Ultima descărcare din IBN: 2024-04-07 12:59 |
SM ISO690:2012 ILICIUC, Ion, RAILEAN, Gheorghe, GUSICOVA, Alexandra, RAILEAN, Anastasia, GUŢU, Arcadie, MAMMADOVA, Ulviyya. Aspectul terapeutic al Ronocitului (CDP-cholina) la copiii cu cefalee migrenoasă. In: Curierul Medical, 2012, nr. 6(330), pp. 42-46. ISSN 1875-0666. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Curierul Medical | ||||||
Numărul 6(330) / 2012 / ISSN 1875-0666 | ||||||
|
||||||
Pag. 42-46 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
We performed a study of the frequency and duration of migraine headaches and specific changes in EEG and dynamics of laboratory changes in serum of cardiolipin, phospholtidilcolin, sphyngomyelin and α-fetoprotein with the immunoferment screening analysis method (ELISA) before and after treatment. Ronocit was administrated parenterally and orally for a period of 40 days at a dose of 1000 mg in two divided doses. While reducing the frequency and duration of headaches in children, an increased lipid metabolism was observed, especially of phospholipids. A parenteral treatment
period of 10 days in patients with migraine headaches were compared with the results from the treatment of children with Cerebral Palsy. By analyzing side effects, of Ronocit in children with migraine headaches and cerebral palsy, we can conclude that no side effects were noted. There was a clinical and
neurophysiological (EEG) improvement in the frequency and duration of migraine access, while increasing antioxidant defense system. This aspect can be used for prophylactic migraine access in children. |
||||||
Cuvinte-cheie Ronocit, immunoferment screening., migraine, headache, Access |
||||||
|